1. Acetylcholinesterase-inhibitors
2. Anticholinergic drugs
3. Antidepressants
4. Antihypertensives
5. Antipsychotics
6. Allergy and Anaphylaxis drugs
7. Antigout (Allopurinol/Antihyperuricemics)
8. Antihyperglycemics
9. Aspirin
10. Benzodiazepines
11. Bisphosphonates
12. Glaucoma-eye-drops
13. Non-selective NSAIDs and cox-2-selective NSAID
14. Opioids
15. Proton pump inhibitors (PPI)
16. Statins
17. Vitamin D & Calcium

Papers

• Linking Patients’ Goals and Priorities to Recommendations for Medication Changes in a Polypharmacy-Focused Structured Clinical Pathway (2023): When we incorporated into TAPER how well do the recommendations map onto the patient’s priorities that were recorded in TaperMD – around half the time the recommendations mapped directly to a patient priority (which is amazing!)
• A Proposed Curricular Framework for an Interprofessional Approach to Deprescribing (2023)
• Deprescribing to optimise health outcomes for frail older people: a double-blind placebo-controlled randomised controlled trial—outcomes of the Opti-med study (2023)
• I think this medicine actually killed my wife’: patient and family perspectives on shared decision-making to optimize medications and safety (2019)
• Making patient values visible in healthcare: a systematic review of tools to assess patient treatment priorities and preferences in the context of multimorbidity (2016): systematic review publication – seeing if anyone had already operationalized in a way suitable for multimorbidity/polypharmacy. Answer was no-one is doing it.

YouTube Videos

• Prescribe for Impact (2023)
• Breaking Up Can Be Hard To Do (2022)